Company intelligence / Profile preview

Zlatomics

Concord, Massachusetts, United Stateszlatomics.com ↗

Ownership: Private
Development stage: Other

Overview

Zlatomics provides expert consulting services to the biotechnology and pharmaceutical industries with a strong emphasis on genomics, gene editing, molecular biology, proteomics, bioinformatics, and related fields. Profits from its consulting division are reinvested into internal R&D for proprietary biotech innovations. The company is led by an experienced scientist with a background in leading projects across academia and industry. There are no public disclosures of clinical results or late-stage pipeline assets as of June 2025.

Modalities: Gene editingRNA therapyDNA-based technologiesSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Zlatomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zlatomics.

Explore the full profile